Showing results (11-20 of 106) with videos related to
Sort By:
Pageof 11
Annual Review of Pharmacology and Toxicology|January 24, 2003
Nitric oxide-releasing drugsClaudio Napoli, Louis J IgnarroCurrent Diabetes Reports|January 25, 2005
Novel features of nitric oxide, endothelial nitric oxide synthase, and atherosclerosisLouis J Ignarro, Claudio NapoliNitric Oxide : Biology and Chemistry|August 5, 2003
Cell density-enhanced expression of inducible nitric oxide synthase in murine macrophages mediated by interferon-betaAaron T Jacobs, Louis J IgnarroThe Journal of Biological Chemistry|December 26, 2002
Nuclear factor-kappa B and mitogen-activated protein kinases mediate nitric oxide-enhanced transcriptional expression of interferon-betaAaron T Jacobs, Louis J IgnarroCirculation Research|January 12, 2002
Nitric oxide donors and cardiovascular agents modulating the bioactivity of nitric oxide: an overviewLouis J Ignarro, Claudio Napoli, Joseph LoscalzoCurrent Pharmaceutical Design|November 30, 2007
Therapeutic approaches in vascular repair induced by adult bone marrow cells and circulating progenitor endothelial cellsClaudio Napoli, Antonio Balestrieri, Louis J IgnarroNature Reviews. Drug Discovery|July 18, 2002
Potential cardioprotective actions of no-releasing aspirinJohn L Wallace, Louis J Ignarro, Stefano FiorucciCardiovascular Research|September 2, 2006
Nutrition, physical activity, and cardiovascular disease: an updateLouis J Ignarro, Maria Luisa Balestrieri, Claudio NapoliAntioxidants (Basel, Switzerland)|December 24, 2021
The Damaging Outcome of the POLAR Phase III Trials Was Due to Avoidable Time-Dependent Redox Interaction between Oxaliplatin and PledOxJan Olof G Karlsson, Per Jynge, Louis J IgnarroAntioxidants (Basel, Switzerland)|March 29, 2023
Exacerbated Neuropathy in POLAR A and M Trials Due to Redox Interaction of PledOx-Associated Mn2+ and Oxaliplatin-Associated Pt2Jan Olof G Karlsson, Per Jynge, Louis J IgnarroPageof 11